Archive · 20 May 2025
Pfizer India Shares Surge Following Strong Earnings, Dividends
Pfizer, a pharmaceutical company, saw its stock price jump almost 12% after reporting good financial results.
Their profits went way up, about 85%, compared to last year.
They also announced a big dividend, like giving extra money to their shareholders.
The company's sales also grew.
While the stock price has risen recently, it is still below some longer-term averages.
Experts have different views on what might happen next, with some suggesting the price could go higher, but others think it might be time to sell.
Pfizer's stock rose nearly 12% on Tuesday.
The increase followed strong earnings reported for the March 2025 quarter.
Net profit rose 85% to Rs 330.94 crore compared to the previous year.
Pfizer declared a total dividend of Rs 165 per share for FY25.
The stock is in the overbought zone, and some analysts suggest booking profit.
- Who
- Pfizer Ltd.
- What
- Pfizer's stock price rose due to strong earnings and dividends.
- When
- The quarter ending March 2025; Stock rose on Tuesday.
- Where
- Stock exchanges in India
- Why
- Driven by strong earnings and a large dividend.
Optimistic View
Cautious View
Short-term Outlook
Optimistic View
Arpit Beriwal suggests the stock could rally towards Rs 5,200.
Cautious View
The stock is in the overbought zone, and some traders may consider booking profits.
- Stock Price Increase
- 11.91%
- Closing Price High
- Rs 4,995.85
- Net Profit (Jan-Mar 2025)
- Rs 330.94 crore
- Net Profit Increase
- 85%
- Total Dividend (FY25)
- Rs 165 per share
- Revenue Increase
- 8%
